Antibiotic Access & Capacity
December 2021
This proposal is the result of a grassroots endeavour to explore and present solutions to extensive issues surrounding access to and capacity for novel antibiotics in Canada. Jointly led by McMaster University and the Canadian Antimicrobial Innovation Coalition (CAIC), this project was catalyzed by the urgent need to slow the spread of antimicrobial resistance (AMR).
This work resulted in a set of 30 concise recommendations and an integrated solution designed to improve antibiotic access and capacity, and to protect these vital medications through stewardship efforts and improved surveillance of resistance rates in Canada.
Strengthening Governance of the Antimicrobial Resistance Response Across One Health In CANADA
June 2021
This report, designed to recommend two feasible, credible, and sustainable governance model options to strengthen the AMR response in Canada, was co-developed with Sinai Health and commissioned by the Public Health Agency of Canada (PHAC). Despite the many challenges imposed by the COVID-19 pandemic, hundreds of stakeholders from across the human health, agri-food/animal, and environmental domains actively contributed to a year-long consultation process, which formed the bedrock of this proposal. The results were two distinct models: a centralized agency-like model and a distributed network-like model. This file was submitted to PHAC for deliberation.
Combating Antimicrobial Resistance in Canada: Listening Session with Pharmacists to Inform Public Policy Incentives
February 2020
This report, penned by IIDR trainees on behalf of the Canadian Anti-Infection Innovation Network (CAIN), details findings from a listening session held with Canadian pharmacists. These sessions explored best practices for treating MDR infections, prescription SOPs, challenges with stewardship, policy incentives, and more.